Biotech Sector Working to Combat Rising Cases of Colorectal Cancer in Young Adults
USA News Group Commentary
VANCOUVER, BC, May 28, 2024 /PRNewswire/ — USA News Group – Rates of cancer of the colorectal and anal regions have been on the rise for years in young adults, according to surgeons at Yale Medicine. As well, there are now alarming reports around the world of rising diagnoses of HIV, which is being linked to higher anal cancer mortality for women. Worldwide, improved access to testing led to a 4.2% increase in HIV diagnoses in the EU and a whopping 120% increase in Montreal, Canada. With sufferers of these types of cancers seemingly getting younger, and at increased danger for those also diagnosed with HIV, biotech companies are working to improve our chances to beat this category of cancers, including work from Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX:ONC), TScan Therapeutics, Inc. (NASDAQ: TCRX), Bristol-Myers Squibb Company (NYSE: BMY), PDS Biotechnology Corporation (NASDAQ: PDSB), and C4 Therapeutics, Inc. (NASDAQ: CCCC).